The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Lippis Daniel J. since 2024.
This trader's CIK number is 2004380.
At the time of last reporting, Lippis Daniel J. was the CVP, JAPAC of Edwards Lifesciences Corp. (stock ticker symbol EW).
Also see all insider trading activities at Edwards Lifesciences Corp.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | EW | 0 | $0 | 6,144 | $472,988 | 2,030 | $91,910 |
| 2024 | EW | 0 | $0 | 7,821 | $662,318 | 7,821 | $317,561 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-07-28 | EW | Sale | 4,114 | 79.46 | 326,902 |
| 2025-05-09 | EW | Option Ex | 330 | 45.28 | 14,941 |
| 2025-05-09 | EW | Sale | 330 | 74.42 | 24,559 |
| 2025-04-08 | EW | Sale | 300 | 70.61 | 21,183 |
| 2025-04-08 | EW | Option Ex | 300 | 45.28 | 13,583 |
| 2025-03-10 | EW | Sale | 400 | 69.48 | 27,792 |
| 2025-03-10 | EW | Option Ex | 400 | 45.28 | 18,110 |
| 2025-02-13 | EW | Option Ex | 500 | 45.28 | 22,638 |
| 2025-02-13 | EW | Sale | 500 | 76.34 | 38,170 |
| 2025-01-16 | EW | Option Ex | 500 | 45.28 | 22,638 |
| 2025-01-16 | EW | Sale | 500 | 68.76 | 34,382 |
| 2024-12-16 | EW | Option Ex | 2,500 | 45.28 | 113,192 |
| 2024-12-16 | EW | Sale | 2,500 | 74.08 | 185,195 |
| 2024-07-11 | EW | Option Ex | 500 | 45.28 | 22,638 |
| 2024-07-11 | EW | Sale | 500 | 94.18 | 47,090 |
| 2024-06-20 | EW | Option Ex | 535 | 45.28 | 24,223 |
| 2024-06-20 | EW | Sale | 535 | 90.00 | 48,150 |
| 2024-05-07 | EW | Sale | 857 | 85.60 | 73,359 |
| 2024-05-07 | EW | Option Ex | 857 | 36.75 | 31,494 |
| 2024-05-07 | EW | Sale | 857 | 85.60 | 73,359 |
| 2024-05-07 | EW | Option Ex | 857 | 36.75 | 31,494 |
| 2024-04-09 | EW | Option Ex | 857 | 36.75 | 31,494 |
| 2024-04-09 | EW | Sale | 857 | 92.34 | 79,135 |
| 2024-03-07 | EW | Option Ex | 1,715 | 36.75 | 63,026 |
| 2024-03-07 | EW | Sale | 1,715 | 90.98 | 156,030 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lippis Daniel J. (CVP, JAPAC of Edwards Lifesciences Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.